Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by donmayneon Mar 02, 2022 11:30am
265 Views
Post# 34475112

Communication, communication, communication

Communication, communication, communicationOPEN LETTER TO VIEMED

Dear VieMed,

The quotation below was found in from "Apples to Apples: CFA Institute Centre for Financial Market Integrity/ Business Roundtable Institute for Corporate Ethics A Template for Reporting Quarterly Earnings"

https://www.cfainstitute.org/-/media/documents/article/position-paper/template-for-reporting-quarterly-earnings.ashx

They discuss and confirm the summary of recommendations from “Breaking the Short-Term Cycle”
"Corporate leaders, asset managers, investors, and analysts should:
1. Reform earnings guidance practices: All groups should reconsider the benefits and consequences of providing and relying upon focused, quarterly earnings guidance and each group’s involvement in the “earnings guidance game.”
2. Develop long-term incentives across the board: Compensation for corporate executives and asset managers should be structured to achieve long-term strategic and value-creation goals.
3. Demonstrate leadership in shifting the focus to long-term value creation.
4. Improve communications and transparency: More meaningful, and potentially more frequent, communications about company strategy and longterm value drivers can lessen the financial community’s dependence on earnings guidance.
5. Promote broad education of all market participants about the benefits of long-term thinking and the costs of short-term investing.
"

VieMed appears to embrace a difference set of principles.  Investors have no idea of your long term strategy given that over the past 8-quarters VieMed has moved into one business after another and we find out after the fact. Management incentive compensation is blindly given in an unrelenting formulaic fashion that is often hidden from shareholders and benefits from share volatility not growth.  Phantom shares are indeed a phantom menace because the performance criteria appears to shareholders as being not relevant.  What are the long term value creation plans and the metrics that go with that. Almost no transparency to shareholders.  Imagine one of your employees or children saying, "If you don't hear from me, assume I am fine. Trust me."  The short-term thinking in reporting has caused short-term investing as the share price gyrates from unbelievable highs to unbelievable lows.  

It is not lost upon shareholders that interim results were provided leading up to the expiry of management options in 2020 and sale of shares. The share price responded to that. Yet hospital access during the Omicron wave was much more severe than the initial wave and shareholders are indeed concerned. The only difference between 2020 and 2022 is there is no expiring of management options this year.  

Issues to be addressed in the upcoming conference call:
Guidance for FY 2022 (not just Q1 2022)
Growth expectations in core business
Plans to attract new investors after a significant departure of short-term institutional investing
VA status
Reimbursement status
The hiring spree given the stunted growth
Plans for increased transparency! 

As one of the worst performers in terms of share price decline, a rethink of strategy will only benefit the company.  

Sincerely,

A concerned shareholder





<< Previous
Bullboard Posts
Next >>